tiprankstipranks

Knight Therapeutics price target lowered to C$6.25 from C$6.75 at Stifel

Stifel analyst Justin Keywood lowered the firm’s price target on Knight Therapeutics (KHTRF) to C$6.25 from C$6.75 and keeps a Buy rating on the shares.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue